PureTech Share News (PRTC)

PureTech Information

Buy PRTC Shares
Add PRTC to Watchlist
Add PRTC to Alert

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 221.00

Bid: 221.00

Ask: 222.50

Change: -1.50 (-0.67%)

Spread: 1.50 (0.679%)

Open: 222.50

High: 225.00

Low: 219.00

Prev. Close: 222.50

Last checked at -

UK earnings, trading statements calendar - next 7 days

Tue, 22nd Aug 2023 15:46

Wednesday 23 August
Angling Direct PLC	Trading Statement
Costain Group PLC	Half Year Results
Thursday 24 August
Benchmark Holdings PLC	Q3 Results
CRH PLC	Half Year Results
Harbour Energy PLC	Half Year Results
Hays PLC	Full Year Results
Hunting PLC	Half Year Results
James Cropper PLC	Half Year Results
Macfarlane Group PLC	Half Year Results
Princess Private Equity Holding Ltd	Half Year Results
Redcentric PLC	Full Year Results
South32 Ltd	Full Year Results
Tribal Group PLC	Half Year Results
Friday 25 August
no events scheduled
Monday 28 August
no events scheduled
Tuesday 29 August
Amaroq Minerals Ltd	Half Year Results
Bunzl PLC	Half Year Results
Dalata Hotel Group PLC	Half Year Results
Faron Pharmaceuticals Ltd	Half Year Results
PureTech Health PLC	Half Year Results

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

8 Jul 2020 15:13

Peel Hunt says Vor Biopharma cash call validates Puretech Health's model

(Sharecast News) - Analysts at Peel Hunt reiterated their 'Conviction Buy' recommendation for shares of PureTech Health following a $110.0m funding round for its founded entity Vor Biopharma, arguing that the transaction validated its business model.

7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

23 Jun 2020 07:29

PureTech's Akili gets CE-mark for 'EndeavourRx'

(Sharecast News) - Biotherapeutics company PureTech Health said its founded entity Akili had received a CE-mark for 'EndeavorRx treatment for attention deficit hyperactivity disorder (ADHD).

18 Jun 2020 18:49

IN BRIEF: Puretech Health Partners With China Medical System

16 Jun 2020 14:34

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

16 Jun 2020 07:29

PureTech gets FDA clearance for video game ADHD treatment

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that its subsidiary Akili has been granted US Food and Drug Administration (FDA) clearance for 'EndeavorRx', or AKL-T01, as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).

9 Jun 2020 13:25

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

9 Jun 2020 08:40

PureTech Health sees 'positive' topline data from Phase 1 on IBD candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health reported some "positive" topline data from two Phase 1 studies into VE202, its orally-administered inflammatory bowel disease treatment candidate.

4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

2 Jun 2020 07:37

PureTech firm Gelesis gets Europe approval for 'Plenity'

(Sharecast News) - Clinical stage biotherapeutics company PureTech Health announced on Tuesday that its founded company Gelesis has received approval to market 'Plenity', a novel weight-loss treatment, in Europe.

28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

28 May 2020 07:57

PureTech to advance LYT-100 as potential Covid treatment

(Sharecast News) - PureTech Health announced plans on Thursday to advance its wholly-owned clinical-stage product candidate 'LYT-100', or deupirfenidone, as a potential treatment for serious respiratory complications, including inflammation and fibrosis, that persist following the resolution of Covid-19 infection.

26 May 2020 14:22

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

26 May 2020 08:51

PureTech Health lowers stake in founded entity

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics.

Latest Share Chat

PureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account